Sulfamonomethoxine

Sulfamonomethoxine

SCHEMBL93784

COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 1.00
ALDH1A1 P00352 9/20 0.67
LMNA P02545 3/20 0.66
CYP3A4 P08684 1/20 0.66
HTR6 P50406 1/20 0.66
SMN1; SMN2 Q16637 3/20 0.64
KMT2A Q03164 7/20 0.58
MEN1 O00255 6/20 0.55
ESR1 P03372 1/20 0.55
GAA P10253 1/20 0.52
MAPT P10636 2/20 0.51
ADRA1A P35348 1/20 0.51
KDM4E B2RXH2 1/20 0.51
PDE4A P27815 1/20 0.50
AGO2 Q9UKV8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamonomethoxine SCHEMBL29362359 1.00 CYP2C19 (1.00) CYP2C19ALDH1A1LMNACYP3A4HTR6
Sulfamonomethoxine SCHEMBL11052075 0.99 CYP2C19 (0.97) CYP2C19ALDH1A1LMNACYP3A4HTR6
Sulfamonomethoxine SCHEMBL28198185 0.95 CYP2C19 (0.90) CYP2C19ALDH1A1LMNACYP3A4HTR6
Sulfamonomethoxine SCHEMBL28223172 0.93 CYP2C19 (0.86) CYP2C19ALDH1A1LMNACYP3A4HTR6
Sulfamonomethoxine SCHEMBL28121677 0.89 CYP2C19 (0.80) CYP2C19ALDH1A1LMNACYP3A4HTR6
SCHEMBL25442187 0.86 CYP2C19 (0.76) CYP2C19ALDH1A1LMNACYP3A4HTR6
SCHEMBL31633227 0.86 CYP2C19 (0.75) CYP2C19ALDH1A1LMNASMN1; SMN2KMT2A
Sulfamonomethoxine SCHEMBL28121694 0.86 CYP2C19 (0.73) CYP2C19ALDH1A1LMNACYP3A4HTR6
SCHEMBL5449937 0.84 CYP2C19 (0.73) CYP2C19ALDH1A1LMNACYP3A4HTR6
SCHEMBL2177837 0.81 CYP2C19 (0.68) CYP2C19ALDH1A1LMNACYP3A4HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2890 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035350-A1 METHOD FOR SYNTHESIZING SULFAMONOMETHOXINE NANHAI BEISHA PHARMACEUTICAL CO LTD (CN) 2026-02-05 US claimed
US-12529704-B2 Methods for objective assessment of stress, early detection of risk for stress disorders, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2026-01-20 US claimed
CN-120195301-A Method and system for detecting various antibiotics in water based on artificial intelligence 广东中加检测技术股份有限公司 2025-06-24 CN claimed
CN-118465149-B Pretreatment method for improving analysis efficiency of various antibiotics in organic fertilizer 生态环境部南京环境科学研究所 2025-06-13 CN claimed
CN-120078900-A Nanometer delivery system with double functions of acoustic power and immunoregulation, preparation method and application thereof 深圳先进技术研究院 2025-06-03 CN claimed
CN-120022890-A Granular activated carbon supported cobalt-iron bimetallic catalyst and preparation method and application thereof 浙江农林大学 2025-05-23 CN claimed
CN-119936254-A Method for simultaneously screening 56 drug residues in animal-derived hot pot food materials based on high-resolution mass spectrometry technology 重庆市食品药品检验检测研究院 2025-05-06 CN claimed
CN-119915935-A Synchronous detection method for 42 antibiotics in river mouth multi-environment medium 华东师范大学 2025-05-02 CN claimed
US-12274830-B2 Nitric oxide inhalation therapy for infants with bronchiolitis BEYOND AIR LTD (IL) 2025-04-15 US claimed
CN-119528842-A Method for regulating and controlling drug crystal form through oxidized nanocellulose and application 上海工程技术大学 2025-02-28 CN claimed
US-5354563-A Water dispersion containing ultrafine particles of organic compounds RESEARCH DEVELOPMENT CORP. OF JAPAN (JP) 1994-10-11 US claimed
EP-0422097-B1 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO DAVIS MICHAEL H (US) 1994-04-27 EP claimed
CN-1082031-A The preparation method of sulfamonomethoxine XIAOYI PHARMACEUTICAL FACTORY (CN) 1994-02-16 CN claimed
EP-0117080-B1 SKIN TREATMENT COMPOSITION UNILEVER PLC (GB) 1992-04-08 EP claimed
EP-0422097-A4 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO 1992-03-11 EP claimed
EP-0209403-B1 PROCESS FOR PREPARING ULTRAFINE PARTICLES OF ORGANIC COMPOUNDS Research Development Corporation of Japan (JP) 1991-10-23 EP claimed
EP-0422097-A1 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO. DAVIS MICHAEL H (US) 1991-04-17 EP claimed
US-4913865-A Process for preparing ultrafine particles of organic compounds RESEARCH DEVELOPMENT CORP OF JAPAN (JP) 1990-04-03 US claimed
WO-1990000055-A1 METHOD OF INHIBITING THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN VIVO DAVIS MICHAEL H (US) 1990-01-11 WO claimed
EP-0209403-A2 Process for preparing ultrafine particles of organic compounds Research Development Corporation of Japan (JP) 1987-01-21 EP claimed